Clinical trial
Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
NCT01254838 is registered in ClinicalTrials.gov with Iwate Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Peptide Vaccination for Patients With Advanced Renal Cell Carcinoma
- Lead sponsor
- Iwate Medical University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- December 31, 2010
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma